Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation

Open access
Cheng, Jie, Shah, Yatrik M., Ma, Xiaochao, Pang, Xiaoyan, Tanaka, Toshiya, Kodama, Tatsuhiko, Krausz, Kristopher W., Gonzalez, Frank J.·2010·The Journal of Pharmacology and Experimental Therapeutics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/jpet.110.170225

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

    Koo, H. L., & DuPont, H. L. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328333dc8d · Cited by 189 · cited 1×

    “Rifaximin [Rifax; Xifaxan; 4-deoxy-4 -methylpyrido[1 ,2 1,2]imidazo[5,4-c]rifamycin SV], a nonsystemic rifamycin-derived antibiotic that exhibits low gastrointestinal absorption while retaining potent antibacterial activity (Koo and DuPont, 2010), was approved in 2004 for the treatment of traveler’s diarrhea (Laustsen…”
    Background

Show all 1 references

Cited by

See all 163

Metadata

Authors
Cheng, J., Shah, Y. M., Ma, X., Pang, X., Tanaka, T., Kodama, T., Krausz, K. W., & Gonzalez, F. J.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
2010-10
Volume
335
Issue
1
Pages
32-41
ISSN
0022-3565 (ISSN-L)
OpenAlex
W2106225676
Cited by
163
References
1
FWCI
6.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation. https://app.cochat.ai/papers/10.1124/jpet.110.170225
The paper
Cheng, J., Shah, Y. M., Ma, X., Pang, X., Tanaka, T., Kodama, T., Krausz, K. W., & Gonzalez, F. J. (2010). Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.110.170225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.